Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.

We attempted to reverse multidrug resistance (MDR) by treatment with 25-mer antisense phosphorothioate oligonucleotide. The phosphorothioate analogs, the sequences of which are sense or antisense to the initiation codon of mouse mdr1 mRNA, were tested against murine leukemic P388/S and adriamycin-resistant P388/ADR cell lines. A weak inhibitory effect on the growth of P388/S and P388/ADR cells was observed at a sense and antisense oligonucleotide concentration of 30 microM. Using the monoclonal antibody to P-glycoprotein and a flow cytometry technique, we showed that the level of expression of P-glycoprotein in P388/ADR cells treated with antisense oligonucleotide was lower than when treated with sense oligonucleotide. The antisense oligonucleotide potentiated the growth-inhibitory effect of vinblastine on P388/ADR cells, whereas sense oligonucleotide did not. This was accompanied by an increase in vinblastine retention in the cells. The reversal of the resistance by antisense oligonucleotide was increased by the combination with 1 microM verapamil. These results suggest that the antisense oligonucleotide and low dose verapamil may be useful in circumventing the resistance to anticancer drugs of MDR tumors.

[1]  S. Gollapudi,et al.  Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. , 1992, Cancer letters.

[2]  K. Jeang,et al.  Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. , 1994, Human gene therapy.

[3]  B I Sikic,et al.  Multidrug resistance in lymphomas. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. McPherson,et al.  Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[5]  J. Minna,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.

[6]  R. L. Felsted,et al.  P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies. , 1990, Molecular pharmacology.

[7]  L. Papucci,et al.  Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. , 1994, Oncology research.

[8]  R. West,et al.  The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia. , 1994, British Journal of Cancer.

[9]  T. Hasegawa,et al.  Effect of Staurosporine Derivatives on Protein Kinase Activity and Vinblastine Accumulation in Mouse Leukaemia P388/ADR Cells , 1993, The Journal of pharmacy and pharmacology.

[10]  H. Schreier,et al.  The new frontier: gene and oligonucleotide therapy. , 1994, Pharmaceutica acta Helvetiae.

[11]  A. Dritschilo,et al.  Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. , 1993, Biochemical and biophysical research communications.

[12]  T. Hasegawa,et al.  Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. , 1993, Cancer research.

[13]  B. Sproat,et al.  Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. , 1993, Journal of medicinal chemistry.

[14]  W. G. Tarpley,et al.  P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype. , 1990, British Journal of Cancer.

[15]  W. Scheithauer,et al.  Clinical trials of agents that reverse multidrug resistance. A literature review , 1993, Cancer.

[16]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[17]  F. Asselbergs,et al.  Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells. , 1993, European journal of biochemistry.

[18]  R. Wagner.  Gene inhibition using antisense oligodeoxynucleotides , 1994, Nature.

[19]  T. Tsuruo,et al.  Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line , 1990, International journal of cancer.

[20]  B. Sikic,et al.  Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene , 1993, Pharmacotherapy.

[21]  T. Tsuruo,et al.  Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. , 1989, Cancer research.

[22]  T. Tsuruo,et al.  Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. , 1991, Cancer research.

[23]  M. Volm,et al.  Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. , 1993, Oncology.

[24]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[25]  S. Akiyama,et al.  Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. , 1989, Biochimica et biophysica acta.

[26]  S. Freier,et al.  Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. , 1991, The Journal of biological chemistry.